Actemra

In the US, Actemra (tocilizumab systemic) is a member of the drug class interleukin inhibitors and is used to treat Juvenile Idiopathic Arthritis and Rheumatoid Arthritis.

US matches:

• Actemra

Ingredient matches for Actemra

Tocilizumab

Tocilizumab is reported as an ingredient of Actemra in the following countries:

• Australia


• Japan


• Russian Federation


• Switzerland


• United States

International Drug Name Search